Search results
Author(s):
Charalampos Varlamos
,
Ioannis Lianos
,
Despoina-Rafailia Benetou
,
et al
Added:
2 years ago
Proximal Side Optimization
Author(s):
Francesco Lavarra
Added:
3 years ago
Article
Author(s):
Abdulrahman Almoghairi
,
Nayef Al-Asiri
,
Khalid Al Johani
,
et al
Added:
9 months ago
Author(s):
Ali Nazmi Calik
,
F Aaysha Cader
,
Erik Rafflenbeul
,
et al
Added:
8 months ago
Author(s):
Arditya Damarkusuma
Added:
1 month ago
In this video, Dr Arditya Damarkusuma (Universitas Gadjah Mada, ID) presents his case report on aorto-ostial lesions, recently published in ICR Journal.This case covers the restenosis of a markedly protruding stent at the right coronary ostium in a 54-year old man, and is unusual in its 10-year longevity. Intravascular ultrasound-guided in-stent restenosis intervention using a wire bumper…
View more
Author(s):
Kendra J Grubb
Added:
1 year ago
Dr Kendra Grubb (Emory Structural Heart and Valve Center, GA, US) outlines the interim analysis of the Optimize PRO Study (NCT04091048), originally presented at EuroPCR 2022.
Optimize PRO aimed to evaluate valve performance and procedural outcomes of optimised TAVR care using Medtronic's Evolut™ PRO and Evolut™ PRO+ devices.
Findings are promising and show that no patients experienced a…
View more
Author(s):
Gaku Nakazawa
,
Aloke V Finn
,
Renu Virmani
Added:
3 years ago
Polymer-based sirolimus (Cypher®) and paclitaxel (Taxus®) drug-eluting stents (DES) have reduced rates of restenosis and target lesion revascularization (TLR) compared with bare-metal stents (BMS) and have launched a revolution in the interventional treatment of symptomatic coronary artery disease.1,2 However, this overwhelming enthusiasm has recently been dampened by safety concerns regarding a…
View more
Author(s):
Mirvat Alasnag
Added:
11 months ago
EuroPCR 23 — We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have a impact on interventional science and clinical practice.
Trials covered in detail include:
EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary…
View more
Author(s):
Peter J Fitzgerald
,
Martin B Leon
Added:
3 years ago
An unintended consequence of the market success of drug-eluting stents has been a growing concern about their safety and safety-related costs. These devices have been so quickly and widely adopted that their market penetration already equals that of some of the most popular pharmaceutical drugs. Consequently, the absolute significance of even a low incidence of side effects becomes magnified by…
View more
Author(s):
Daniel J Pelchovitz
,
Robert L Wilensky
Added:
3 years ago
Vasa vasora are the blood supply of the artery itself, originating in the adventitia in response to the arterial wall’s nutritional requirements. The presence of a thicker tunica media or neointima requires the development of vasa vasorum to meet the metabolic demands of the arterial wall, since diffusion from the arterial lumen alone is insufficient. Over 40 years ago Wolinsky and Glagov…
View more